← Eichor
Study identifier: NCT06142032 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Support Groups in the Metaverse for Ukrainian Refugees

Condition: Mental Health Wellness 1 · Well-Being, Psychological  ·  Sponsor: University of Bucharest

PhaseNA
Planned participants45
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersYes

About this study

The goal of this clinical trial is to test the efficacy of support groups held in the Metaverse, designed to promote mental health and well-being in Ukrainian refugees. Participants: * will be allocated to one of three conditions: (1) Metaverse support group (intervention); (2) In-Person support group (intervention); or (3) Waitlist. * will be asked to participate in 5 support group sessions, once per week, for each intervention condition. The Metaverse support groups will be compared with the In-Person support groups and with the Waitlist, to test: * the efficacy of the Metaverse condition compared to the In-Person condition. * the efficacy of the intervention conditions compared to the waitlist.

This description comes directly from the study's public registry record.

Talk to the study team

Cezar Giosan, PhD  ·  +40730908050  ·  giosan@outlook.com

Always discuss trial participation with your own doctor first.

Locations (1)

University of BucharestBucharest, RomaniaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06142032